| human | Q5 |
| P2080 | AcademiaNet ID | 1145107 |
| P1280 | CONOR.SI ID | 197659491 |
| P13049 | DDB person (GND) ID | 112785751 |
| P8168 | FactGrid item ID | Q885057 |
| P4872 | GEPRIS person ID | 1531434 |
| P227 | GND ID | 112785751 |
| P2671 | Google Knowledge Graph ID | /g/12nx6w316 |
| P1960 | Google Scholar author ID | CKcpeCoAAAAJ |
| P2273 | HAdW member ID | 392 |
| P213 | ISNI | 0000000137199592 |
| P10299 | Leopoldina member ID (new) | marcella-rietschel |
| P3413 | Leopoldina member ID (superseded) | 7470 |
| P244 | Library of Congress authority ID | n2008039007 |
| P1153 | Scopus author ID | 16741658400 |
| P10013 | SNSF person ID | 563505 |
| P214 | VIAF cluster ID | 204329898 |
| P10832 | WorldCat Entities ID | E39PBJpV4KHY7Fd9j3TrHf4cyd |
| P27 | country of citizenship | Germany | Q183 |
| P108 | employer | ZI Mannheim | Q190621 |
| P101 | field of work | genome-wide association study | Q1098876 |
| schizophrenia | Q41112 | ||
| bipolar disorder | Q131755 | ||
| P735 | given name | Marcella | Q1068231 |
| Marcella | Q1068231 | ||
| P1412 | languages spoken, written or signed | German | Q188 |
| P463 | member of | German Academy of Sciences Leopoldina | Q543804 |
| Heidelberg Academy for Sciences and Humanities | Q833738 | ||
| P1559 | name in native language | Marcella Rietschel | |
| P106 | occupation | psychiatrist | Q211346 |
| geneticist | Q3126128 | ||
| university teacher | Q1622272 | ||
| P21 | sex or gender | female | Q6581072 |
| Q56988894 | 274. MIR137 Influences White Matter Fractional Anisotropy and Cortical Surface Area in Individuals with High Genetic Risk for Psychosis |
| Q48765875 | 5-HT2A receptor and bipolar affective disorder: association studies in affected patients |
| Q47869628 | 5-HTTLPR/rs25531 polymorphism and neuroticism are linked by resting state functional connectivity of amygdala and fusiform gyrus |
| Q24538720 | A Gene for Universal Congenital Alopecia Maps to Chromosome 8p21-22 |
| Q59791266 | A Longitudinal Approach to Biological Psychiatric Research: The PsyCourse Study |
| Q37635614 | A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease |
| Q43113117 | A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients |
| Q48309066 | A common microdeletion affecting a hippocampus- and amygdala-specific isoform of tryptophan hydroxylase 2 is not associated with affective disorders |
| Q41207528 | A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder |
| Q57316463 | A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects |
| Q57655421 | A family-based and case–control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder |
| Q43608191 | A family-based study of the Cys23Ser 5HT2C serotonin receptor polymorphism in schizophrenia |
| Q40189266 | A functional variant in the neuropeptide S receptor 1 gene moderates the influence of urban upbringing on stress processing in the amygdala |
| Q35069476 | A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder |
| Q35530520 | A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder |
| Q57321063 | A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q |
| Q41201382 | A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis |
| Q24655759 | A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder |
| Q33740277 | A genome-wide association study of alcohol dependence |
| Q43756830 | A genome-wide significant linkage for severe depression on chromosome 3: the depression network study |
| Q38423702 | A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects |
| Q45885056 | A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval |
| Q49020541 | A genomewide linkage study on suicidality in major depressive disorder confirms evidence for linkage to 2p12. |
| Q33727503 | A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia |
| Q59791234 | A longitudinal approach to biological psychiatric research: The PsyCourse study. |
| Q29417093 | A mega-analysis of genome-wide association studies for major depressive disorder |
| Q57655278 | A new susceptibility locus for bipolar affective disorder in PAR1 on Xp22.3/Yp11.3 |
| Q35045447 | A phenotypic structure and neural correlates of compulsive behaviors in adolescents |
| Q57655483 | A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25–q26 |
| Q48789053 | A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe |
| Q33798551 | A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry |
| Q57317115 | A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry |
| Q44818850 | A risk variant for alcoholism in the NMDA receptor affects amygdala activity during fear conditioning in humans |
| Q48516684 | A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci |
| Q50577090 | A systematic association mapping on chromosome 6q in bipolar affective disorder--evidence for the melanin-concentrating-hormone-receptor-2 gene as a risk factor for bipolar affective disorder |
| Q39529050 | A target sample of adolescents and reward processing: same neural and behavioral correlates engaged in common paradigms? |
| Q50692425 | ADH1B Arg48His allele frequency map: filling in the gap for Central Europe |
| Q46040061 | Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis. |
| Q57655619 | Adenosine A1 receptor and bipolar affective disorder: systematic screening of the gene and association studies |
| Q34031695 | Adolescent impulsivity phenotypes characterized by distinct brain networks |
| Q35000528 | Adverse reactions to antidepressants |
| Q57655488 | Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia? |
| Q47938273 | Age at onset in bipolar I affective disorder: further evidence for three subgroups |
| Q55034093 | Agranulocytosis during treatment with mianserin and venlafaxine. |
| Q48085024 | Alterations of Glucocorticoid Receptor Gene Methylation in Externalizing Disorders During Childhood and Adolescence |
| Q39795321 | Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for Schizophrenia |
| Q39399664 | Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking |
| Q40397660 | An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype |
| Q57403475 | An association study of a neurotrophic3 (NT-3) gene polymorphism with schizophrenia |
| Q57655778 | An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia |
| Q37805713 | An integrated genome research network for studying the genetics of alcohol addiction |
| Q38465159 | An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses |
| Q34469246 | Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. |
| Q37412924 | Analysis of Rare Variants in the Alcohol Dependence Candidate Gene GATA4 |
| Q48293685 | Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia |
| Q34449361 | Analysis of genome-wide significant bipolar disorder genes in borderline personality disorder |
| Q55128222 | Analysis of shared heritability in common disorders of the brain |
| Q64964428 | Apolipoprotein E Homozygous ε4 Allele Status: A Deteriorating Effect on Visuospatial Working Memory and Global Brain Structure. |
| Q51004657 | Apolipoprotein E genotype distribution in schizophrenia. |
| Q57655653 | Apolipoprotein E ɛ4 and clinical phenotype in schizophrenia |
| Q33664040 | Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies |
| Q57403463 | Assessing the statistical power to detect linkage in a sample of 51 bipolar affective disorder pedigrees |
| Q34804607 | Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report |
| Q57742003 | Association Between Population Density and Genetic Risk for Schizophrenia |
| Q57083811 | Association Study of Nonsynonymous Single Nucleotide Polymorphisms in Schizophrenia |
| Q57655294 | Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder |
| Q42950843 | Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls |
| Q57655781 | Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German-British sample of manic depressive patients and controls |
| Q42108870 | Association and linkage studies in bipolar affective disorder |
| Q40309411 | Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression |
| Q45176969 | Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study |
| Q28140603 | Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder |
| Q59619218 | Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder |
| Q28200777 | Association between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorder |
| Q33700749 | Association between a serotonin transporter length polymorphism and primary insomnia |
| Q43561820 | Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample |
| Q50633310 | Association between dopa decarboxylase gene variants and borderline personality disorder |
| Q49061405 | Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe |
| Q40598546 | Association between neuropeptide Y receptor Y2 promoter variant rs6857715 and major depressive disorder |
| Q45075170 | Association between schizophrenia and common variation in neurocan (NCAN), a genetic risk factor for bipolar disorder |
| Q34517004 | Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder |
| Q36785936 | Association of Protein Phosphatase PPM1G With Alcohol Use Disorder and Brain Activity During Behavioral Control in a Genome-Wide Methylation Analysis |
| Q57515292 | Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank |
| Q44776875 | Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia |
| Q46185206 | Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes |
| Q48165250 | Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity |
| Q51742566 | Association of the DTNBP1 genotype with cognition and personality traits in healthy subjects |
| Q47978434 | Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women |
| Q47379437 | Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia |
| Q57655388 | Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder |
| Q46482684 | Association study between genetic variants at the VAMP2 and VAMP3 loci and bipolar affective disorder |
| Q44063108 | Association study between two variants in the DOPA decarboxylase gene in bipolar and unipolar affective disorder |
| Q57655298 | Association study of 20 genetic variants at the D-amino acid oxidase gene in schizophrenia |
| Q57655405 | Association study of a functional promoter polymorphism in theXBP1 gene and schizophrenia |
| Q57655659 | Association study of schizophrenia and the histidase gene |
| Q57655233 | Association study of the GRIA1 and CLINT1 (Epsin 4) genes in a German schizophrenia sample |
| Q57655514 | Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controls |
| Q51808997 | At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia |
| Q53379617 | Attitudes towards predictive genetic testing for Alzheimer's disease |
| Q48339716 | BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study |
| Q35179012 | BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study |
| Q36791063 | BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks |
| Q35592821 | Bipolar polygenic loading and bipolar spectrum features in major depressive disorder |
| Q46096011 | Body weight as a predictor of antidepressant efficacy in the GENDEP project |
| Q50643822 | Boys do it the right way: Sex-dependent amygdala lateralization during face processing in adolescents |
| Q48102784 | Brain function in carriers of a genome-wide supported bipolar disorder variant |
| Q34583423 | Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder |
| Q50309857 | Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin |
| Q57655690 | CNTF and psychiatric disorders |
| Q34128396 | COMT val158met polymorphism and neural pain processing |
| Q50786670 | CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. |
| Q73362925 | CYP2D6 Polymorphism and Tardive Dyskinesia in Schizophrenic Patients |
| Q55455346 | Cacna1c haploinsufficiency leads to pro-social 50-kHz ultrasonic communication deficits in rats. |
| Q30694085 | Can long-range microsatellite data be used to predict short-range linkage disequilibrium? |
| Q34143977 | Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area |
| Q45405623 | Catechol-O-methyltransferase Val158 Met genotype, parenting practices and adolescent alcohol use: testing the differential susceptibility hypothesis |
| Q52931795 | Caught in the trio trap? Potential selection bias inherent to association studies using parent-offspring trios |
| Q47418955 | Changes in body weight during pharmacological treatment of depression |
| Q40691027 | Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1α) and RORA. |
| Q39988302 | City living and urban upbringing affect neural social stress processing in humans |
| Q68112660 | Clinical variability of autosomal dominant spinal muscular atrophy |
| Q28282304 | Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia |
| Q36817134 | Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial |
| Q50663179 | Cognitive state and connectivity effects of the genome-wide significant psychosis variant in ZNF804A. |
| Q34114516 | Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q |
| Q40794290 | Combining clinical variables to optimize prediction of antidepressant treatment outcomes |
| Q44539729 | Commingling analysis of age-of-onset in bipolar I disorder and the morbid risk for major psychoses in first degree relatives of bipolar I probands |
| Q34028001 | Common and rare variant analysis in early-onset bipolar disorder vulnerability |
| Q45331135 | Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes |
| Q34458961 | Common genetic variants influence human subcortical brain structures |
| Q45764658 | Common structural correlates of trait impulsiveness and perceptual reasoning in adolescence |
| Q35816788 | Common variants at VRK2 and TCF4 conferring risk of schizophrenia |
| Q24614376 | Common variants conferring risk of schizophrenia |
| Q37173580 | Common variants on 8p12 and 1q24.2 confer risk of schizophrenia |
| Q46141284 | Common variation in NCAN, a risk factor for bipolar disorder and schizophrenia, influences local cortical folding in schizophrenia |
| Q39495606 | Comparison of gene expression profiles in the blood, hippocampus and prefrontal cortex of rats |
| Q36090063 | Computer-assisted phenotype characterization for genetic research in psychiatry |
| Q41269744 | Concordance of Phantom and Residual Limb Pain Phenotypes in Double Amputees: Evidence for the Contribution of Distinct and Common Individual Factors |
| Q41073238 | Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis |
| Q34145283 | Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants |
| Q43599808 | Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene |
| Q36850500 | Converging Evidence for Epistasis between ANK3 and Potassium Channel Gene KCNQ2 in Bipolar Disorder |
| Q48367416 | Copy number variants and therapeutic response to antidepressant medication in major depressive disorder |
| Q34811896 | Copy number variants in German patients with schizophrenia |
| Q35900760 | Copy number variations of chromosome 16p13.1 region associated with schizophrenia |
| Q33372366 | Correlations between risk gene variants for schizophrenia and brain structure anomalies |
| Q48483813 | Cortical thickness of superior frontal cortex predicts impulsiveness and perceptual reasoning in adolescence |
| Q52806735 | Cortisol, cortisone, and BDNF in amniotic fluid in the second trimester of pregnancy: Effect of early life and current maternal stress and socioeconomic status |
| Q50637827 | Creating probabilistic maps of the face network in the adolescent brain: a multicentre functional MRI study |
| Q48430397 | D2 antidopaminergic modulation of frontal lobe function in healthy human subjects |
| Q30474546 | DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis |
| Q43202776 | DNA sequence variants of the FKBP5 gene are associated with unipolar depression |
| Q34068888 | DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance |
| Q45056693 | DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population |
| Q37208565 | Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms |
| Q51939970 | Depression, migraine with aura and migraine without aura: their familiality and interrelatedness |
| Q32142716 | Description of the Genetic Analysis Workshop 10 bipolar disorder linkage data sets |
| Q57405116 | Description of the Genetic Analysis Workshop 10 bipolar disorder linkage data sets |
| Q58554692 | Detecting significant genotype-phenotype association rules in bipolar disorder: market research meets complex genetics |
| Q35760224 | Determinants of early alcohol use in healthy adolescents: the differential contribution of neuroimaging and psychological factors |
| Q46104577 | Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression |
| Q34202425 | Dimensions of manic symptoms in youth: psychosocial impairment and cognitive performance in the IMAGEN sample |
| Q24647095 | Disruption of the neurexin 1 gene is associated with schizophrenia |
| Q43483239 | Dissecting the genetic heterogeneity of depression through age at onset |
| Q41882634 | Dissecting the phenotype in genome-wide association studies of psychiatric illness |
| Q34974229 | Dissection of phenotype reveals possible association between schizophrenia and Glutamate Receptor Delta 1 (GRID1) gene promoter |
| Q37626678 | Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking |
| Q48606866 | Disturbed cortico-amygdalar functional connectivity as pathophysiological correlate of working memory deficits in bipolar affective disorder |
| Q48385311 | Disturbed frontal gyrification within families affected with schizophrenia |
| Q47992809 | Do you see what I see? Sex differences in the discrimination of facial emotions during adolescence |
| Q46643230 | Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium |
| Q57321107 | Dopamine D2 receptor molecular variant and schizophrenia |
| Q57655695 | Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases |
| Q57655528 | Dopamine D3 receptor variant and tardive dyskinesia |
| Q34287598 | Dopamine inactivation efficacy related to functional DAT1 and COMT variants influences motor response evaluation |
| Q38617731 | Drinking water to reduce alcohol craving? A randomized controlled study on the impact of ghrelin in mediating the effects of forced water intake in alcohol addiction |
| Q54613289 | Dual association of a TRKA polymorphism with schizophrenia. |
| Q37360523 | Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence |
| Q34086260 | Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study |
| Q40790836 | Effect of copy number variant burden on Global Assessment of Functioning in schizophrenia |
| Q56353844 | Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies |
| Q33506534 | Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects |
| Q60610010 | Effects of BDNF Val66Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans |
| Q58117305 | Effects of BDNF ValMet genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans |
| Q44490894 | Effects of a CACNA1C genotype on attention networks in healthy individuals |
| Q48271431 | Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task |
| Q57155883 | Effects of leptin and ghrelin on neural cue-reactivity in alcohol addiction: Two streams merge to one river? |
| Q51858168 | Effects of the circadian rhythm gene period 1 (per1) on psychosocial stress-induced alcohol drinking |
| Q50946700 | Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor |
| Q30425785 | Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene |
| Q52809131 | Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis |
| Q45832362 | Efficient strategy for detecting gene × gene joint action and its application in schizophrenia |
| Q57296426 | Elevated expression of a minor isoform of ANK3 is a risk factor for bipolar disorder |
| Q47899207 | Epigenetic alteration of the dopamine transporter gene in alcohol-dependent patients is associated with age. |
| Q38814364 | Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells |
| Q57405062 | Erratum to “Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder”, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics”, April 1; 156(3):370-378 |
| Q57268473 | Erratum: Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function and bipolar disorder susceptibility |
| Q57405038 | Erratum: Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder |
| Q50770651 | Estimating the heritability of reporting stressful life events captured by common genetic variants |
| Q35951576 | Etiopathogenetic mechanisms in long-term course of schizophrenia |
| Q57655252 | European collaborative study of early-onset bipolar disorder: Evidence for genetic heterogeneity on 2q14 according to age at onset |
| Q57655572 | Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families |
| Q48479637 | Evidence for a Sex-Dependent MAOA× Childhood Stress Interaction in the Neural Circuitry of Aggression |
| Q48819378 | Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression |
| Q51034630 | Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder |
| Q77628575 | Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study |
| Q35622119 | Expanding the range of ZNF804A variants conferring risk of psychosis |
| Q38668022 | Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist |
| Q35780023 | Exploring the role of drug-metabolising enzymes in antidepressant side effects |
| Q36709678 | FTO, obesity and the adolescent brain |
| Q57655626 | Familial occurrence of primary premature ejaculation |
| Q57655477 | Familial occurrence of tardive dyskinesia |
| Q35711708 | Familiality and SNP heritability of age at onset and episodicity in major depressive disorder |
| Q52089742 | Familiality of symptom dimensions in depression |
| Q33827638 | Family and genetic studies on the relationship of schizophrenia to affective disorders |
| Q51980857 | Family history influences age of onset in bipolar I disorder in females but not in males |
| Q47868051 | Family-based association studies of alpha-adrenergic receptor genes in chromosomal regions with linkage to bipolar affective disorder |
| Q44411867 | Family‐based and case–control study of catechol‐O‐methyltransferase in schizophrenia among Palestinian Arabs |
| Q47556833 | Fast sleep spindle density is associated with rs4680 (Val108/158Met) genotype of Catechol-O-Methyltransferase (COMT). |
| Q51890078 | Forum: The interplay of genes and environment in psychiatric disorders |
| Q45767530 | From gene to brain to behavior: schizophrenia-associated variation in AMBRA1 alters impulsivity-related traits |
| Q41013453 | From mother to child: orbitofrontal cortex gyrification and changes of drinking behaviour during adolescence |
| Q37660158 | From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders |
| Q21090982 | Functional connectivity analyses in imaging genetics: considerations on methods and data interpretation |
| Q37065287 | Functional impact of a recently identified quantitative trait locus for hippocampal volume with genome-wide support |
| Q38772337 | Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomains |
| Q48096146 | Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations? |
| Q28270257 | Functional polymorphism of the dopamine β-hydroxylase gene is associated with increased risk of disulfiram-induced adverse effects in alcohol-dependent patients |
| Q40037150 | Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia |
| Q46493040 | Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia |
| Q52239350 | Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis |
| Q57655475 | Further evidence for age of onset being an indicator for severity in bipolar disorder |
| Q37642441 | Further evidence for the impact of a genome-wide-supported psychosis risk variant in ZNF804A on the Theory of Mind Network |
| Q51892719 | G72 and its association with major depression and neuroticism in large population-based groups from Germany |
| Q37642029 | GABRB1 Single Nucleotide Polymorphism Associated with Altered Brain Responses (but not Performance) during Measures of Impulsivity and Reward Sensitivity in Human Adolescents |
| Q33691275 | GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia |
| Q33696761 | Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia |
| Q48612091 | Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment |
| Q43135420 | Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients |
| Q47290653 | Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder |
| Q28943470 | Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort |
| Q34181876 | Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders |
| Q57605591 | Genetic Architecture of Subcortical Brain Structures in Over 40,000 Individuals Worldwide |
| Q38675906 | Genetic Contribution to Alcohol Dependence: Investigation of a Heterogeneous German Sample of Individuals with Alcohol Dependence, Chronic Alcoholic Pancreatitis, and Alcohol-Related Cirrhosis |
| Q53203060 | Genetic association in psychiatric diseases. Concepts and findings |
| Q45292101 | Genetic counseling in psychiatric diseases |
| Q45729383 | Genetic differences in cytochrome P450 enzymes and antidepressant treatment response |
| Q56347335 | Genetic disposition to inflammation and response to antidepressants in major depressive disorder |
| Q35150158 | Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate |
| Q34431154 | Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? |
| Q48372657 | Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study |
| Q45916412 | Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. |
| Q46051862 | Genetic predictors of response to antidepressants in the GENDEP project |
| Q28484419 | Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis |
| Q28296286 | Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs |
| Q35023117 | Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study |
| Q37172778 | Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents |
| Q36746449 | Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study |
| Q43998568 | Genetic variants of lipase activity in chronic pancreatitis |
| Q48360954 | Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia |
| Q38434718 | Genetic variation in CACNA1C affects neural processing in major depression |
| Q48952710 | Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans |
| Q38374868 | Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals |
| Q38381112 | Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals |
| Q42672368 | Genetic variation in the G72 gene is associated with increased frontotemporal fiber tract integrity |
| Q38382619 | Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals |
| Q49114492 | Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals |
| Q46161875 | Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with personality traits in healthy individuals |
| Q57315185 | Genetic variation of the 5-HT2A receptor and response to clozapine |
| Q44125800 | Genetics of bipolar affective disorders. Current status of research for identification of susceptibility genes |
| Q38282574 | Genetics of chronic post-surgical pain: a crucial step toward personal pain medicine |
| Q30573253 | Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode |
| Q35608277 | Genetics of schizophrenia and affective disorders |
| Q57321088 | Geneties of Schizophrenia and Bipolar Affective Disorder |
| Q22242975 | Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder |
| Q49236384 | Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar Disorder |
| Q52560096 | Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression |
| Q41392222 | Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis |
| Q28943374 | Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder |
| Q29417107 | Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder |
| Q30559089 | Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder |
| Q37280609 | Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo |
| Q29417016 | Genome-wide association of mood-incongruent psychotic bipolar disorder |
| Q37831225 | Genome-wide association studies of alcohol dependence and substance use disorders |
| Q24634497 | Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder |
| Q40103441 | Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis |
| Q37528290 | Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder |
| Q29417149 | Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder |
| Q39732399 | Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder |
| Q57700323 | Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder |
| Q28943321 | Genome-wide association study of alcohol dependence |
| Q38669045 | Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia |
| Q44670236 | Genome-wide association study of co-occurring anxiety in major depression |
| Q49024786 | Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project |
| Q39674863 | Genome-wide association study of pathological gambling |
| Q37226546 | Genome-wide association study of suicide attempts in mood disorder patients |
| Q40215640 | Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness |
| Q28235753 | Genome-wide association study reveals two new risk loci for bipolar disorder |
| Q48105260 | Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression |
| Q46022556 | Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD. |
| Q42655084 | Genome-wide pharmacogenetics of antidepressant response in the GENDEP project |
| Q35962736 | Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14 |
| Q36589726 | Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1. |
| Q35631745 | Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster |
| Q29417060 | Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci |
| Q50779938 | Genome-wide supported risk variant for bipolar disorder alters anatomical connectivity in the human brain |
| Q46504843 | Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder |
| Q28742939 | Genomewide association scan of suicidal thoughts and behaviour in major depression |
| Q34137467 | Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24. |
| Q57697186 | Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes |
| Q42682091 | Genomic architecture of human neuroanatomical diversity |
| Q57317095 | Genotype-phenotype association mining in bipolar disorder: market research meets complex genetics |
| Q51924518 | Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes |
| Q48360961 | Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia |
| Q36958010 | HPA-axis activity in alcoholism: examples for a gene-environment interaction |
| Q40669159 | Hair Cortisol and Its Association With Psychological Risk Factors for Psychiatric Disorders: A Pilot Study in Adolescent Twins |
| Q45072666 | Hair Cortisol in Twins: Heritability and Genetic Overlap with Psychological Variables and Stress-System Genes |
| Q68095267 | Heterogeneity in proximal spinal muscular atrophy |
| Q37578876 | High frequencies of de novo CNVs in bipolar disorder and schizophrenia |
| Q40589507 | High loading of polygenic risk in cases with chronic schizophrenia |
| Q46014279 | Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. |
| Q48787188 | Hippocampal function in healthy carriers of the CLU Alzheimer's disease risk variant |
| Q43272941 | History of suicide attempts among patients with depression in the GENDEP project |
| Q57403895 | How Can Pharmacogenomics Biomarkers Be Translated into Patient Benefit |
| Q30511878 | How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure |
| Q34015548 | Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect |
| Q57655718 | Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia |
| Q36301065 | Identification and functional characterization of rare SHANK2 variants in schizophrenia |
| Q40607073 | Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1. |
| Q36792668 | Identification of common variants associated with human hippocampal and intracranial volumes |
| Q43183593 | Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients |
| Q29417130 | Identification of loci associated with schizophrenia by genome-wide association and follow-up |
| Q37381091 | Identification of rare variants in KCTD13 at the schizophrenia risk locus 16p11.2. |
| Q37506744 | Identifying bipolar disorder susceptibility loci in a densely affected pedigree |
| Q36791694 | Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance |
| Q42616379 | Impact of age at first drink on vulnerability to alcohol-related problems: testing the marker hypothesis in a prospective study of young adults |
| Q44914335 | Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting |
| Q49709780 | Impact of prenatal stress on mother-infant dyadic behavior during the still-face paradigm |
| Q45916877 | Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism. |
| Q34018777 | Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals |
| Q52563148 | Impact on birth weight of maternal smoking throughout pregnancy mediated by DNA methylation |
| Q37114489 | Implication of a rare deletion at distal 16p11.2 in schizophrenia |
| Q36350246 | Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers |
| Q40461734 | Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders. |
| Q48014635 | Increased medial orbitofrontal and amygdala activation: evidence for a systems-level endophenotype of bipolar I disorder |
| Q50744596 | Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development |
| Q44280112 | Independent evidence for the selective influence of GABA(A) receptors on one component of the bipolar disorder phenotype |
| Q48381860 | Induction and quantification of prefrontal cortical network plasticity using 5 Hz rTMS and fMRI. |
| Q43268912 | Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia |
| Q33716541 | Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia |
| Q40701790 | Interacting effect of MAOA genotype and maternal prenatal smoking on aggressive behavior in young adulthood |
| Q45927860 | Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. |
| Q44985331 | Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample |
| Q40908751 | Interaction between COMT Val(158)Met polymorphism and childhood adversity affects reward processing in adulthood |
| Q46036202 | Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. |
| Q46103432 | Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults |
| Q39392604 | Interaction between the FTO gene, body mass index and depression: meta-analysis of 13701 individuals |
| Q47432706 | Interactive effects of corticotropin-releasing hormone receptor 1 gene and childhood adversity on depressive symptoms in young adults: findings from a longitudinal study |
| Q56967644 | Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study |
| Q45758985 | Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution |
| Q57655670 | Investigation of Complement C4B Deficiency in Schizophrenia |
| Q30313279 | Investigation of SHANK3 in schizophrenia |
| Q35150183 | Investigation of blood mRNA biomarkers for suicidality in an independent sample |
| Q50104375 | Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB1-, and DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia |
| Q34113404 | Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder |
| Q55039294 | Investigation of the DAOA/G30 locus in panic disorder. |
| Q57655519 | Investigation of the human serotonin 6 (5HT6) receptor gene in bipolar affective disorder and schizophrenia |
| Q73994286 | Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia |
| Q45076450 | Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients |
| Q34429146 | Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia |
| Q40283155 | Investigation of the role of TCF4 rare sequence variants in schizophrenia |
| Q50793156 | Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics |
| Q57655469 | Is there a phenotypic difference between probands in case-control versus family-based association studies? |
| Q34820222 | KCNJ6 is associated with adult alcohol dependence and involved in gene × early life stress interactions in adolescent alcohol drinking |
| Q58838762 | Khat abuse as risk factor for development of psychotic symptoms in trauma patients. A feasibility study for further genetico-epidemiological studies in the GGFRC, ethiopia |
| Q42362286 | Khat use and occurrence of psychotic symptoms in the general male population in Southwestern Ethiopia: evidence for sensitization by traumatic experiences |
| Q57655480 | Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia |
| Q51915062 | Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case-control study |
| Q50797144 | Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probands of European origin |
| Q24654741 | Large recurrent microdeletions associated with schizophrenia |
| Q48135978 | Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial |
| Q47704367 | Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia |
| Q35903759 | Leveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS. |
| Q35877868 | Linkage-disequilibrium-based binning affects the interpretation of GWASs |
| Q44709355 | Longer telomere length in patients with schizophrenia |
| Q34465904 | Low Birth Weight in MZ Twins Discordant for Birth Weight is Associated with Shorter Telomere Length and lower IQ, but not Anxiety/Depression in Later Life |
| Q48150808 | Lower ventral striatal activation during reward anticipation in adolescent smokers |
| Q52048108 | MASA syndrome: clinical variability and linkage analysis |
| Q35159992 | Machine learning patterns for neuroimaging-genetic studies in the cloud |
| Q47597788 | Major psychoses symptomatology: factor analysis of 2241 psychotic subjects |
| Q48893196 | Manual dexterity correlating with right lobule VI volume in right-handed 14-year-olds |
| Q36591215 | Maternal interpersonal affiliation is associated with adolescents' brain structure and reward processing |
| Q36193455 | Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness |
| Q34699544 | Measuring depression: comparison and integration of three scales in the GENDEP study |
| Q28607353 | Mechanisms of disturbed emotion processing and social interaction in borderline personality disorder: state of knowledge and research agenda of the German Clinical Research Unit |
| Q48891135 | Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline |
| Q41887769 | Mental disorders are somatic disorders, a comment on M. Stier and T. Schramme |
| Q30574842 | Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility |
| Q29417150 | Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. |
| Q36731415 | Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement |
| Q24634151 | Microduplications of 16p11.2 are associated with schizophrenia |
| Q44091008 | Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter |
| Q39261297 | Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood |
| Q45945437 | Moderation of antidepressant response by the serotonin transporter gene. |
| Q36120530 | Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder |
| Q57419522 | Mood-incongruent psychosis in bipolar disorder: conditional linkage analysis shows genome-wide suggestive linkage at 1q32.3, 7p13 and 20q13.31 |
| Q36772668 | Mouse and Human Genetic Analyses Associate Kalirin with Ventral Striatal Activation during Impulsivity and with Alcohol Misuse |
| Q28290169 | Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. |
| Q44246923 | Multiple polymorphisms in genes of the adrenergic stress system confer vulnerability to alcohol abuse |
| Q53208023 | Mutation in the beta amyloid precursor protein gene and schizophrenia |
| Q36059932 | NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression |
| Q47745417 | Neural Mechanism of a Sex-Specific Risk Variant for Posttraumatic Stress Disorder in the Type I Receptor of the Pituitary Adenylate Cyclase Activating Polypeptide |
| Q48630669 | Neural and cognitive correlates of the common and specific variance across externalizing problems in young adolescence |
| Q36802404 | Neural basis of reward anticipation and its genetic determinants |
| Q37480474 | Neural correlates of three types of negative life events during angry face processing in adolescents |
| Q34978645 | Neural mechanisms of a genome-wide supported psychosis variant |
| Q50740202 | Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype |
| Q45176739 | Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder |
| Q44341707 | Neuroimaging evidence for a role of neural social stress processing in ethnic minority-associated environmental risk |
| Q24289323 | Neuropsychosocial profiles of current and future adolescent alcohol misusers |
| Q33856171 | New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? |
| Q30988023 | New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis |
| Q35237172 | New findings in the genetics of major psychoses |
| Q36177108 | No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study |
| Q51905124 | No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder |
| Q57655377 | No association between genetic variants at the ASCT1 gene and schizophrenia or bipolar disorder in a German sample |
| Q57655349 | No association between genetic variants at the DGCR2 gene and schizophrenia in a German sample |
| Q34524820 | No association between genetic variants at the GLYT2 gene and bipolar affective disorder and schizophrenia |
| Q51912625 | No association between genetic variants at the GRIN1 gene and bipolar disorder in a German sample |
| Q46174283 | No association between the D-aspartate oxidase locus and schizophrenia |
| Q73307600 | No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population |
| Q34430435 | No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples |
| Q44634716 | No association between the serine racemase gene (SRR) and bipolar disorder in a German case-control sample |
| Q51905122 | No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample |
| Q48807243 | No differences in hippocampal volume between carriers and non-carriers of the ApoE ε4 and ε2 alleles in young healthy adolescents |
| Q48733397 | No differences in ventral striatum responsivity between adolescents with a positive family history of alcoholism and controls |
| Q48338618 | No evidence for an association between variants at the gamma-amino-n-butyric acid type A receptor beta2 locus and schizophrenia |
| Q46644940 | No evidence for an association between variants at the proline dehydrogenase locus and schizophrenia or bipolar affective disorder |
| Q48249386 | No evidence for an involvement of copy number variation in ABCA13 in schizophrenia, bipolar disorder, or major depressive disorder |
| Q57655385 | No evidence for association between NOTCH4 and schizophrenia in a large family-based and case???control association analysis |
| Q51966473 | No evidence for linkage by transmission disequilibrium test analysis of microsatellite marker D22S278 and schizophrenia in a Palestinian Arab and in a German population |
| Q68202235 | No evidence for linkage of autosomal dominant proximal spinal muscular atrophies to chromosome 5q markers |
| Q57655760 | No evidence of association between dopamine D4 receptor variants and bipolar affective disorder |
| Q46116416 | No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression |
| Q48718603 | Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder |
| Q37598396 | Novel genetic loci associated with hippocampal volume |
| Q27653381 | Novel genetic loci underlying human intracranial volume identified through genome-wide association |
| Q36340727 | Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults |
| Q39304932 | Oxytocin receptor genotype modulates ventral striatal activity to social cues and response to stressful life events |
| Q47437520 | Oxytocin receptor polymorphism and childhood social experiences shape adult personality, brain structure and neural correlates of mentalizing |
| Q35844094 | PCLO rs2522833 impacts HPA system activity in healthy young adults |
| Q33755391 | Parents' Attitudes toward Clinical Genetic Testing for Autism Spectrum Disorder-Data from a Norwegian Sample |
| Q38909428 | Parents' attitudes toward genetic research in autism spectrum disorder |
| Q43962534 | Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity |
| Q48522448 | Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder |
| Q57655767 | Pemphigus chronicus benignus familiaris (Morbus Hailey-Hailey) und bipolare affektive Erkrankung bei drei Mitgliedern einer Familie |
| Q40832000 | Perceived stress and hair cortisol: Differences in bipolar disorder and schizophrenia |
| Q48381594 | Perceived stress has genetic influences distinct from neuroticism and depression |
| Q38953918 | Personality and substance use: psychometric evaluation and validation of the Substance Use Risk Profile Scale (SURPS) in English, Irish, French, and German adolescents |
| Q35653692 | Personality, Attentional Biases towards Emotional Faces and Symptoms of Mental Disorders in an Adolescent Sample |
| Q77500757 | Pharmacogenetics in psychiatry satellite meeting at the American College of Neuropsychopharmacology, 2000 |
| Q49567721 | Pharmacogenetics in psychiatry: state of the art |
| Q40350674 | Pharmacogenetics of antidepressant response: A polygenic approach |
| Q57655504 | Pharmacogenetics of clozapine response |
| Q33920521 | Pharmacogenetics of schizophrenia |
| Q44026650 | Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism |
| Q36498543 | Phenotypic Association Analyses With Copy Number Variation in Recurrent Depressive Disorder |
| Q38721029 | Polygenic risk for depression and the neural correlates of working memory in healthy subjects |
| Q50154396 | Polygenic risk for schizophrenia affects working memory and its neural correlates in healthy subjects |
| Q46308032 | Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples |
| Q34637787 | Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents |
| Q45004422 | Population pharmacokinetic analysis of mirtazapine |
| Q35122070 | Positive association of video game playing with left frontal cortical thickness in adolescents |
| Q51899983 | Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample |
| Q50702569 | Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients |
| Q38668070 | Predicting Response to Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia Using Structural Magnetic Resonance Imaging: A Multisite Machine Learning Analysis |
| Q40753501 | Prediction of alcohol drinking in adolescents: Personality-traits, behavior, brain responses, and genetic variations in the context of reward sensitivity |
| Q48629811 | Prefrontal-temporal gray matter deficits in bipolar disorder patients with persecutory delusions |
| Q35899373 | Pregnancy and spinal muscular atrophy |
| Q47568233 | Preliminary Evidence for an Association Between Variants of the Catechol-O-Methyltransferase (COMT) Gene and Premature Ejaculation |
| Q51905743 | Premorbid adjustment in schizophrenia--an important aspect of phenotype definition |
| Q51735547 | Premorbid adjustment: a phenotype highlighting a distinction rather than an overlap between schizophrenia and bipolar disorder |
| Q34542443 | Prevalence of depression, suicidal ideation, alcohol intake and nicotine consumption in rural Central India. The Central India Eye and Medical Study |
| Q35043972 | Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder |
| Q51898903 | Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). |
| Q36485264 | RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release |
| Q33853853 | RETRACTED: Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain |
| Q46346887 | Randomized parcellation based inference |
| Q43163365 | Rare SHANK2 variants in schizophrenia |
| Q34311849 | Reduced anxiety and depression-like behaviours in the circadian period mutant mouse afterhours |
| Q35112156 | Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia |
| Q48133791 | Reduction of the internal capsule in families affected with schizophrenia |
| Q51969140 | Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia |
| Q33827099 | Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study |
| Q52169386 | Reliability and validity of the German version of the Premorbid Adjustment Scale (PAS) |
| Q50536197 | Reliability and validity of the premorbid adjustment scale (PAS) in a German sample of schizophrenic and schizoaffective patients |
| Q51800023 | Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study |
| Q42649058 | Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects |
| Q35913898 | Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study |
| Q44227113 | Replication study and meta-analysis in European samples supports association of the 3p21.1 locus with bipolar disorder |
| Q57405074 | Reply to “Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression” |
| Q57317108 | Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients |
| Q42907735 | Retraction for Dixson et al., Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain |
| Q48873883 | Risk taking and the adolescent reward system: a potential common link to substance abuse |
| Q42946738 | Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning |
| Q52995774 | Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels |
| Q47885230 | Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume |
| Q48548848 | SCN1A affects brain structure and the neural activity of the aging brain |
| Q34313985 | Segment-wise genome-wide association analysis identifies a candidate region associated with schizophrenia in three independent samples |
| Q58791217 | Self-rated depression and eye diseases: The Beijing Eye Study |
| Q32022721 | Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients |
| Q34291371 | Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study |
| Q73446247 | Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings |
| Q34393039 | Sex differences in COMT polymorphism effects on prefrontal inhibitory control in adolescence |
| Q51732834 | Sex differences in symptom patterns of recurrent major depression in siblings |
| Q59109394 | Sex modulates the interaction between neuropeptide S gene variants and endocrine and central stress responses |
| Q46013624 | Sex-specific association between functional neuropeptide S receptor gene (NPSR1) variants and cortisol and central stress responses. |
| Q46106156 | Sex-specific association between the 5-HTT gene-linked polymorphic region and basal cortisol secretion |
| Q34982204 | Sex-specific role for adenylyl cyclase type 7 in alcohol dependence |
| Q39448090 | Sexual Function Is Correlated With Body Image and Partnership Quality in Female University Students |
| Q35755912 | Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. |
| Q49123194 | Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view |
| Q55724398 | Shared genetic etiology between alcohol dependence and major depressive disorder. |
| Q28658523 | Single nucleotide polymorphism in the neuroplastin locus associates with cortical thickness and intellectual ability in adolescents |
| Q57655754 | Single-strand conformation analysis (SSCA) of the dopamine D1 receptor gene (DRD1) reveals no significant mutation in patients with schizophrenia and manic depression |
| Q48592646 | Smoking behaviour: investigation of the coaction of environmental and genetic risk factors |
| Q59295223 | Spina Bifida |
| Q42977848 | Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. |
| Q47790538 | Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia |
| Q40547311 | Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia |
| Q39289822 | Structural brain correlates of adolescent resilience |
| Q34297764 | Studies in humans and mice implicate neurocan in the etiology of mania |
| Q36391763 | Study protocol of the ASD-Net, the German research consortium for the study of Autism Spectrum Disorder across the lifespan: from a better etiological understanding, through valid diagnosis, to more effective health care |
| Q48073994 | Subthreshold depression and regional brain volumes in young community adolescents |
| Q51897139 | Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment |
| Q21245266 | Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial |
| Q33210741 | Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristics |
| Q40722387 | Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families |
| Q55052082 | Supporting evidence for LRRTM1 imprinting effects in schizophrenia. |
| Q36148471 | Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function |
| Q44022700 | Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior |
| Q57655518 | Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) |
| Q57655680 | Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder |
| Q45163438 | Systematic screening for mutations in the human N-methyl-D-aspartate receptor 1 gene in schizophrenic patients from the German population |
| Q57655706 | Systematic screening for mutations in the human serotonin 1F receptor gene in patients with bipolar affective disorder and schizophrenia |
| Q57655700 | Systematic screening for mutations in the human serotonin-2A (5-HT 2A ) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia |
| Q71131045 | Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia |
| Q57315186 | Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene |
| Q48248036 | TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies |
| Q42694576 | The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients |
| Q38738856 | The 5-HTTLPR Polymorphism Affects Network-Based Functional Connectivity in the Visual-Limbic System in Healthy Adults |
| Q38670489 | The Andalusian Bipolar Family (ABiF) Study: Protocol and sample description |
| Q48254927 | The CACNA1C risk variant for bipolar disorder influences limbic activity |
| Q37239901 | The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations |
| Q33905352 | The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease |
| Q24802094 | The Depression Network (DeNT) Study: methodology and sociodemographic characteristics of the first 470 affected sibling pairs from a large multi-site linkage genetic study |
| Q24289484 | The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data |
| Q37811879 | The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology |
| Q28610572 | The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects |
| Q49121260 | The catechol-O-methyl transferase (COMT) gene and its potential association with schizophrenia: findings from a large German case-control and family-based sample |
| Q51015372 | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia |
| Q47553079 | The effect of 5-HTTLPR and a serotonergic multi-marker score on amygdala, prefrontal and anterior cingulate cortex reactivity and habituation in a large, healthy fMRI cohort |
| Q46317119 | The effect of G72 genotype on neural correlates of memory encoding and retrieval |
| Q48367252 | The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval |
| Q36471529 | The effect of neurogranin on neural correlates of episodic memory encoding and retrieval |
| Q34173810 | The effects of a DTNBP1 gene variant on attention networks: an fMRI study |
| Q36492159 | The first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder: strong evidence of epistatic effects between loci on chromosomes 2q and 6q. |
| Q38061466 | The genetics of alcohol dependence. |
| Q49037932 | The hippocampus in families with schizophrenia in relation to obstetric complications |
| Q48058034 | The human serotonin 7 (5-HT7) receptor gene: genomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder. |
| Q43411797 | The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study |
| Q48825356 | The impact of a Dysbindin schizophrenia susceptibility variant on fiber tract integrity in healthy individuals: a TBSS-based diffusion tensor imaging study |
| Q48513096 | The impact of dystrobrevin-binding protein 1 (DTNBP1) on neural correlates of episodic memory encoding and retrieval |
| Q51909243 | The impact of genetics on psychiatric nosology |
| Q47610838 | The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis |
| Q43279078 | The interaction between the dopamine transporter gene and age at onset in relation to tobacco and alcohol use among 19-year-olds |
| Q39619276 | The inverse link between genetic risk for schizophrenia and migraine through NMDA (N-methyl-D-aspartate) receptor activation via D-serine |
| Q30511830 | The neural basis of video gaming |
| Q24617186 | The neuronal transporter gene SLC6A15 confers risk to major depression |
| Q34482739 | The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder |
| Q45251042 | The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder |
| Q39030396 | The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders |
| Q39294240 | The psychiatric vulnerability gene CACNA1C and its sex-specific relationship with personality traits, resilience factors and depressive symptoms in the general population |
| Q51860518 | The rate of consanguineous marriages among parents of schizophrenic patients in the Arab Bedouin population in Southern Israel |
| Q48027075 | The risk variant in ODZ4 for bipolar disorder impacts on amygdala activation during reward processing |
| Q34213593 | The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms |
| Q37397637 | The structure of psychopathology in adolescence and its common personality and cognitive correlates |
| Q34622650 | Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression |
| Q31077646 | Time-resolved influences of functional DAT1 and COMT variants on visual perception and post-processing |
| Q43253362 | Trajectories of change in depression severity during treatment with antidepressants |
| Q64447869 | Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders |
| Q40259221 | Transcriptomics and the mechanisms of antidepressant efficacy |
| Q24658007 | Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder |
| Q57655732 | Tyrosine hydroxylase gene and manic-depressive illness |
| Q43722416 | Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder |
| Q48348288 | Variability of single trial brain activation predicts fluctuations in reaction time |
| Q45147314 | Variation in GNB3 predicts response and adverse reactions to antidepressants |
| Q46069686 | Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples |
| Q43227791 | Volition diminishes genetically mediated amygdala hyperreactivity |
| Q51909308 | What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics |
| Q37663260 | White-matter microstructure and gray-matter volumes in adolescents with subthreshold bipolar symptoms |
| Q51838428 | Whole genome linkage scan of recurrent depressive disorder from the depression network study |
| Q34429555 | XRCC5 as a risk gene for alcohol dependence: evidence from a genome-wide gene-set-based analysis and follow-up studies in Drosophila and humans |
| Q37699377 | ZNF804A and cortical structure in schizophrenia: in vivo and postmortem studies |
| Q74179425 | [Clinical characteristics of patients with tardive dyskinesias] |
| Q57655546 | hSKCa3: no association of the polymorphic CAG repeat with bipolar affective disorder and schizophrenia |
| Q37030212 | αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior |
| Q57321051 | “Association study of a functional promoter polymorphism in theXBP1 gene and schizophrenia,” American Journal Of Medical Genetics Part B (Neuropsychiatric Genetics) 141B:71–75 (2006) |
| Marcella Rietschel | wikipedia |
Search more.